Cipla soars on inking agreement with Novartis Pharma AG

10 Apr 2023 Evaluate

Cipla is currently trading at Rs. 900.00, up by 7.30 points or 0.82% from its previous closing of Rs. 892.70 on the BSE.

The scrip opened at Rs. 895.10 and has touched a high and low of Rs. 904.05 and Rs. 894.50 respectively. So far 21996 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 1185.20 on 01-Nov-2022 and a 52 week low of Rs. 852.00 on 22-Mar-2023.

Last one week high and low of the scrip stood at Rs. 910.50 and Rs. 885.65 respectively. The current market cap of the company is Rs. 72566.87 crore.

The promoters holding in the company stood at 33.61%, while Institutions and Non-Institutions held 49.47% and 16.91% respectively.

Cipla has signed a perpetual license agreement with Novartis Pharma AG (Switzerland) on April 10, 2023 to manufacture and market Galvus and Galvus combination brands, used in the treatment of type 2 diabetes from January 1, 2026. The agreement is subject to satisfaction of certain conditions precedent. During the interim period it would continues to market and distribute Galvus branded products.

Galvus is one of the leading brands in the Dipeptidyl Peptidase-4 (DPP4) space and amongst the prominent brands in the oral diabetic medication category. Galvus has the potential to contribute significantly to Cipla’s portfolio in the diabetes care continuum space with reported sales of Rs 268 crore (IQVIA MAT February 2023). This deal is expected to further bolster Cipla’s position in India as one of the top players in the diabetes category.

Cipla is a global pharmaceutical company which uses cutting edge technology and innovation to meet the everyday needs of all patients.


Cipla Share Price

1505.05 8.70 (0.58%)
26-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1719.20
Dr. Reddys Lab 1269.05
Cipla 1505.05
Zydus Lifesciences 911.50
Lupin 2112.95
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×